JP2008110984A5 - - Google Patents

Download PDF

Info

Publication number
JP2008110984A5
JP2008110984A5 JP2007316676A JP2007316676A JP2008110984A5 JP 2008110984 A5 JP2008110984 A5 JP 2008110984A5 JP 2007316676 A JP2007316676 A JP 2007316676A JP 2007316676 A JP2007316676 A JP 2007316676A JP 2008110984 A5 JP2008110984 A5 JP 2008110984A5
Authority
JP
Japan
Prior art keywords
methyl
indol
ylsulfanyl
benzyl
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2007316676A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008110984A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2008110984A publication Critical patent/JP2008110984A/ja
Publication of JP2008110984A5 publication Critical patent/JP2008110984A5/ja
Ceased legal-status Critical Current

Links

JP2007316676A 2003-12-23 2007-12-07 2−(1h−インドリルスルファニル)−ベンジルアミン誘導体 Ceased JP2008110984A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53259303P 2003-12-23 2003-12-23
DKPA200301923 2003-12-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006545921A Division JP4090491B2 (ja) 2003-12-23 2004-12-21 2−(1h−インドリルスルファニル)−ベンジルアミン誘導体

Publications (2)

Publication Number Publication Date
JP2008110984A JP2008110984A (ja) 2008-05-15
JP2008110984A5 true JP2008110984A5 (https=) 2008-09-18

Family

ID=34712442

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006545921A Expired - Fee Related JP4090491B2 (ja) 2003-12-23 2004-12-21 2−(1h−インドリルスルファニル)−ベンジルアミン誘導体
JP2007148813A Expired - Lifetime JP4091648B2 (ja) 2003-12-23 2007-06-05 2−(1h−インドリルスルファニル)−ベンジルアミン誘導体
JP2007316676A Ceased JP2008110984A (ja) 2003-12-23 2007-12-07 2−(1h−インドリルスルファニル)−ベンジルアミン誘導体

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2006545921A Expired - Fee Related JP4090491B2 (ja) 2003-12-23 2004-12-21 2−(1h−インドリルスルファニル)−ベンジルアミン誘導体
JP2007148813A Expired - Lifetime JP4091648B2 (ja) 2003-12-23 2007-06-05 2−(1h−インドリルスルファニル)−ベンジルアミン誘導体

Country Status (18)

Country Link
US (4) US7563908B2 (https=)
EP (1) EP1701940B1 (https=)
JP (3) JP4090491B2 (https=)
AT (1) ATE396970T1 (https=)
AU (1) AU2004303461B2 (https=)
BR (1) BRPI0417858B1 (https=)
CY (2) CY1108230T1 (https=)
DE (1) DE602004014190D1 (https=)
DK (1) DK1701940T3 (https=)
ES (1) ES2303960T3 (https=)
HR (2) HRP20080274T3 (https=)
IL (1) IL176111A (https=)
MX (1) MXPA06007172A (https=)
PL (1) PL1701940T3 (https=)
PT (1) PT1701940E (https=)
RS (1) RS50589B (https=)
SI (1) SI1701940T1 (https=)
WO (1) WO2005061455A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS50589B (sr) * 2003-12-23 2010-05-07 H. Lundbeck A/S. 2-(1h-indolilsulfanil)-benzil amin derivati kao ssri
AR052308A1 (es) * 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
AR054393A1 (es) 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
AR054394A1 (es) * 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de 2- (1h-indolilsulfanil)-aril amina
WO2007107165A1 (en) * 2006-03-22 2007-09-27 H. Lundbeck A/S Method for identifying compounds for the treatment of depression
TW200819426A (en) 2006-08-31 2008-05-01 Lundbeck & Co As H Novel indane compounds
CN101563320B (zh) * 2006-09-28 2012-05-30 H.隆德贝克有限公司 用于治疗情感障碍的[2-(6-氟-1h-吲哚-3-基硫烷基)苄基]甲胺
CA2664258A1 (en) 2006-09-28 2008-04-03 H. Lundbeck A/S [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
CN101868233A (zh) * 2007-09-24 2010-10-20 H.隆德贝克有限公司 与血清素双重作用化合物有关的组合疗法
TW200938189A (en) * 2008-03-13 2009-09-16 Lundbeck & Co As H [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
AU2009272900B2 (en) * 2008-07-15 2012-04-19 F. Hoffmann-La Roche Ag Substituted indolyl and indazolyl derivatives and uses thereof
US9000025B2 (en) 2010-08-20 2015-04-07 Amira Pharmaceuticals, Inc. Autotaxin inhibitors and uses thereof
US9260416B2 (en) 2011-05-27 2016-02-16 Amira Pharmaceuticals, Inc. Heterocyclic autotaxin inhibitors and uses thereof
US9714240B2 (en) 2013-09-17 2017-07-25 Pharmakea, Inc. Vinyl autotaxin inhibitor compounds
JP2016530210A (ja) 2013-09-17 2016-09-29 ファーマケア,インク. ヘテロ環式ビニルオートタキシン阻害剤化合物
JP2016531874A (ja) 2013-09-26 2016-10-13 ファーマケア,インク. オートタキシン阻害剤化合物
KR102515248B1 (ko) 2013-11-22 2023-03-29 사브레 테라퓨틱스 엘엘씨 오토탁신 억제제 화합물
MX2017015225A (es) 2015-05-27 2018-02-19 Pharmakea Inc Inhibidores de la autotaxina y sus usos.
WO2018191146A1 (en) 2017-04-10 2018-10-18 Navitor Pharmaceuticals, Inc. Heteroaryl rheb inhibitors and uses thereof

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2003023A (en) * 1930-10-16 1935-05-28 Westinghouse Electric & Mfg Co Mercury vapor or noble gas rectifier with arc control
US3803143A (en) * 1969-09-08 1974-04-09 Eisai Co Ltd 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines
US4018830A (en) * 1969-09-22 1977-04-19 Merck & Co., Inc. Phenylthioaralkylamines
US4055665A (en) * 1974-11-25 1977-10-25 Merck & Co., Inc. Treating arrythmia with phenylthioaralkylamines
US4056632A (en) * 1975-07-21 1977-11-01 Burroughs Wellcome Co. 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
US4198417A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenoxyphenylpiperidines
DE3640475A1 (de) 1986-11-27 1988-06-09 Hoechst Sa Lab Arzneimittel auf basis von derivaten des 3,4-diphenylpiperidins, die verwendung der derivate als arzneimittel sowie neue 3,4-diphenylpiperidinderivate und verfahren zu ihrer herstellung
EP0396827A1 (en) 1989-05-09 1990-11-14 SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu 2-Phenylthiobenzylamine dervivatives and acid addition salts thereof
GB8912971D0 (en) 1989-06-06 1989-07-26 Wellcome Found Halogen substituted diphenylsulfides
US6645969B1 (en) * 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
BR9206810A (pt) * 1991-11-25 1995-10-31 Pfizer Derivados de indol
GB9126311D0 (en) 1991-12-11 1992-02-12 Wellcome Found Substituted diphenylsulfides
GB9226532D0 (en) 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
WO1995029897A1 (en) * 1994-04-29 1995-11-09 G.D. Searle & Co. METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS
JP3897360B2 (ja) 1995-01-23 2007-03-22 第一アスビオファーマ株式会社 虚血性疾患に基づく症状の改善又は治療薬及びそれに有用な化合物
ATE195125T1 (de) 1995-11-06 2000-08-15 Dsm Nv Verfahren zur de-esterifikation
CZ293595A3 (cs) 1995-11-09 1999-12-15 Farmak A. S. Deriváty N,N-dimethyl-2-(arylthio)benzylaminu, jejich soli, způsoby jejich přípravy a jejich použití v léčivých přípravcích
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
JP2000516936A (ja) * 1996-08-27 2000-12-19 アメリカン・ホーム・プロダクツ・コーポレイション ドパミンd2作動薬としておよび5―ht1aリガンドとしての4―アミノエトキシインドール
US5906078A (en) * 1996-10-09 1999-05-25 Gallagher-Kaiser Corporation Retaining strip for sheet covered enclosures
GB9725953D0 (en) 1997-12-08 1998-02-04 Pfizer Ltd Compounds useful in therapy
DE19756036A1 (de) 1997-12-17 1999-06-24 Merck Patent Gmbh Amid- und Harnstoffderivate
US6333146B1 (en) * 1999-03-10 2001-12-25 Fuji Photo Film Co., Ltd. Methine compound and silver halide photographic material containing the same
AU774054B2 (en) 1999-04-02 2004-06-17 Icos Corporation Inhibitors of LFA-1 binding to ICAMs and uses thereof
JP2002543173A (ja) * 1999-04-30 2002-12-17 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルベニア セロトニン輸送体のためのspect画像化剤
MXPA02001160A (es) 1999-08-04 2002-07-02 Millennium Pharm Inc Compuestos que se unen a los receptores para melanocortina-4, y metodo de uso de estos.
US6410736B1 (en) * 1999-11-29 2002-06-25 Pfizer Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
AP2002002481A0 (en) 1999-10-13 2002-06-30 Pfizer Prod Inc Biaryl ether derivatives useful as monoamine reuptake inhibitors.
DE60009154D1 (de) * 1999-12-30 2004-04-22 Lundbeck & Co As H Phenylpiperazinyl-derivate
EA006071B1 (ru) 1999-12-30 2005-08-25 Х.Лундбекк А/С Замещенные производные фенилпиперазина, их получение и применение
IL150366A0 (en) 1999-12-30 2002-12-01 Lundbeck & Co As H 4-phenyl-1-piperazinyl,-piperidinyl and tetrahydropyridyl derivatives
US20020044914A1 (en) * 2000-02-29 2002-04-18 Dooley Thomas P. Inhibitors of melanocyte tyrosinase as topical skin lighteners
CN1251671C (zh) * 2000-05-19 2006-04-19 武田药品工业株式会社 β分泌酶抑制剂
US6455738B1 (en) * 2000-07-13 2002-09-24 Rhodia Chimie Process for the sulfonation of an aromatic compound
WO2002006234A1 (en) * 2000-07-17 2002-01-24 Takeda Chemical Industries, Ltd. Sulfone derivatives, process for their production and use thereof
AU2001279955A1 (en) * 2000-08-18 2002-03-04 Sterix Limited 2-substituted estradiol derivative for inhibiting superoxid dismutase
HUP0500470A3 (en) * 2000-09-01 2005-11-28 Fmc Corp 1,4-disubstituted benzenes as insecticides and use thereof
AU2001288623A1 (en) * 2000-09-05 2002-03-22 Tularik, Inc. Fxr modulators
EP1193268A1 (en) * 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases
US6852816B2 (en) * 2000-10-06 2005-02-08 Biocompatibles Uk Limited Zwitterionic polymers
EP1578341A2 (en) * 2000-10-11 2005-09-28 Tularik Inc. Modulation of ccr4 function
EP1333832B1 (en) 2000-11-14 2007-11-28 MERCK PATENT GmbH Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors
US6436938B1 (en) * 2001-01-22 2002-08-20 Pfizer Inc. Combination treatment for depression
WO2002062766A2 (en) 2001-02-07 2002-08-15 Millennium Pharmaceuticals, Inc. Melanocortin-4 receptor binding compounds and methods of use thereof
EP1401813B1 (en) 2001-06-07 2007-02-07 F. Hoffman-la Roche AG New indole derivatives with 5-ht6 receptor affinity
JPWO2002100833A1 (ja) * 2001-06-12 2004-09-24 住友製薬株式会社 Rhoキナーゼ阻害剤
UA81749C2 (uk) 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
US7064139B2 (en) * 2001-10-29 2006-06-20 Uniroyal Chemical Company, Inc. Method for treating retroviral infections
RU2004117907A (ru) * 2001-11-14 2006-01-10 Шеринг Корпорейшн (US) Лиганды каннабиноидных рецепторов
EP1458704A1 (en) 2001-12-21 2004-09-22 H. Lundbeck A/S Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors
ATE371680T1 (de) * 2002-01-16 2007-09-15 Biocompatibles Uk Ltd Polymerkonjugate
US20050261298A1 (en) * 2002-01-18 2005-11-24 David Solow-Cordero Methods of treating conditions associated with an Edg-7 receptor
ATE440304T1 (de) * 2002-03-01 2009-09-15 Fujifilm Corp Farbphotographisches lichtempfindliches silberhalogenidmaterial
WO2003074538A1 (en) * 2002-03-04 2003-09-12 Japan Science And Technology Agency Novel phosphonamides, process for producing the same, and use thereof
CN1656856B (zh) * 2002-03-29 2013-07-17 麻省理工学院 包含半导体纳米晶体的发光器件
DE10217006A1 (de) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
MXPA04012704A (es) * 2002-06-19 2005-03-23 Schering Corp Agonistas de los receptores canabinoides.
TW200401641A (en) * 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
ES2311721T3 (es) * 2002-09-17 2009-02-16 F. Hoffmann-La Roche Ag Indoles sustituidos en posicion 2,4 y su empleo como moduladores de 5-ht6.
MXPA05002696A (es) * 2002-09-17 2005-05-05 Hoffmann La Roche Indoles 2,7-sustituidos y su uso como moduladores de 5-hidroxitriptamina 6 (5-ht6).
EP1402888A1 (en) * 2002-09-18 2004-03-31 Jerini AG The use of substituted carbocyclic compounds as rotamases inhibitors
US20040266732A1 (en) * 2002-09-20 2004-12-30 Jorge Galvez Therapeutic agents, methods, and treatments
US20060189519A1 (en) * 2002-09-26 2006-08-24 Karl Volz Anti-angiogenic fragments fo pigment epithelium-derived factor (pedf)
US20040137389A1 (en) * 2002-12-19 2004-07-15 Kouta Fukui Heat-developable light-sensitive material
ZA200505523B (en) * 2002-12-20 2006-09-27 Amgen Inc Asthma and allergic inflammation modulators
CN1512264B (zh) * 2002-12-27 2010-05-26 富士胶片株式会社 卤化银彩色照相感光材料
DE10300098A1 (de) * 2003-01-07 2004-07-15 Bayer Ag Kupfer-Carben-Komplexe und ihre Verwendung
EP1590388A2 (en) * 2003-02-05 2005-11-02 Biocompatibles UK Limited Block copolymers
TW200505902A (en) * 2003-03-20 2005-02-16 Schering Corp Cannabinoid receptor ligands
US7893096B2 (en) * 2003-03-28 2011-02-22 Novartis Vaccines And Diagnostics, Inc. Use of small molecule compounds for immunopotentiation
US7244763B2 (en) * 2003-04-17 2007-07-17 Warner Lambert Company Llc Compounds that modulate PPAR activity and methods of preparation
JPWO2005035516A1 (ja) * 2003-10-10 2006-12-21 小野薬品工業株式会社 新規縮合複素環化合物およびその用途
US7229751B2 (en) * 2003-11-20 2007-06-12 Konica Minolta Medical & Graphic, Inc. Silver salt photothermographic dry imaging material and image forming method using the same
US20050250794A1 (en) * 2003-12-19 2005-11-10 Andrew Napper Methods of treating a disorder
RS50589B (sr) * 2003-12-23 2010-05-07 H. Lundbeck A/S. 2-(1h-indolilsulfanil)-benzil amin derivati kao ssri
SE528250C2 (sv) 2004-02-27 2006-10-03 Calignum Technologies Ab Komposition innefattande en initiator och ett förfarande för att behandla trä med kompositionen
JP4569142B2 (ja) * 2004-03-22 2010-10-27 コニカミノルタホールディングス株式会社 表示素子
JP4448730B2 (ja) * 2004-04-20 2010-04-14 富士フイルム株式会社 感光性組成物、該感光性組成物に用いられる化合物及び該感光性組成物を用いたパターン形成方法
WO2006006172A2 (en) 2004-07-15 2006-01-19 Ramot At Tel Aviv University Ltd. Use of anti-amyloid agents for treating and typing pathogen infections
ATE539745T1 (de) 2004-08-19 2012-01-15 Univ Tel Aviv Future Tech Dev Zusammensetzungen zur behandlung von amyloid- assoziierten erkrankungen
EP1793272A4 (en) 2004-08-24 2008-01-23 Fujifilm Corp PHOTOGRAPHIC PHOTOSENSITIVE COLOR MATERIAL BASED ON SILVER HALIDE AND METHOD OF FORMING IMAGES
CA2582658A1 (en) 2004-10-08 2006-04-13 Banyu Pharmaceutical Co., Ltd. Method for producing thioether compound
EP1833894A1 (en) 2004-12-16 2007-09-19 Pirelli & C. S.p.A. Process for manufacturing a thermoplastic elastomeric material

Similar Documents

Publication Publication Date Title
JP2008110984A5 (https=)
RU2361860C2 (ru) Новые замещенные 3-сера-индолы
JP2004512328A5 (https=)
RU2009148673A (ru) Производные пиразинона и их применение для лечения легочных заболеваний
NO20061151L (no) Succinat- og malonatsalt av trans-4-((ir,3s)-6-klor-3-fenylindan-i-yl)-1,2,2-trimetylpiperazin og anvendelsen som et medikament
RU2017127135A (ru) Терапевтическое средство против рака желчных протоков
MY142551A (en) Substituted diaryl heterocycles, process for their preparation and their use as medicaments
JP2007508360A5 (https=)
NO20081482L (no) Delta- og epsilon-krystallformer for imatinibmesylat
JP2016538313A5 (https=)
JP2007519649A5 (https=)
EA200971086A1 (ru) Фармацевтические композиции и способ лечения шизофрении
DK1485094T3 (da) Doseringsform til oral indgivelse af 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phanylamino]-methyl}-1-methyl-1h-benzimi dazol-5-carbonyl)-pyridin-2-yl-amino]-propionsyre-ethylester eller dets salte
JP2011524850A5 (https=)
UA102517C2 (ru) Замещенные производные морфолина и тиоморфолина, фармацевтическая композиция на их основе и их применение для производства лекарственного средства для лечения расстройства или заболевания центральной нервной системы
EA200971087A1 (ru) Фармацевтические композиции и способ лечения острой мании
JP2011500697A5 (https=)
EA202090029A1 (ru) Твердая композиция карипразина для орального введения
NO20085271L (no) Muscarin reseptoragonister som er effektive i behandling av smerte, Alzheimers sykdom og schizofreni
NZ590839A (en) Treatment of pulmonary arterial hypertension
RU2006130000A (ru) Органические соединения
CL2008003053A1 (es) Compuestos derivados de (4-(piperazin-1-il)fenil)-amida del acido isoxazol-4-carboxilico; composicion farmaceutica, util para tratar tejido nervioso, depresion, ansiedad, adiccion a drogas, falla cardiaca, desordenes del sueno, obesidad, desordenes metabolicos, entre otras, a travez de la modulacion del receptor npy y2.
ATE495159T1 (de) Diaminocyclohexan- und diaminocyclopentanderivate
JP2012528824A5 (https=)
JP2003518022A5 (https=)